LOS ANGELES, CA--(Marketwire - August 20, 2008) - Clearant, Inc. (OTCBB: CLRA), owner of the Clearant Process® designed to substantially reduce all types of pathogens in biological products including HIV, today announced that revenues for the second quarter period ending June 30, 2008 increased 194% to a record $0.50 million from $0.17 million in the same period of 2007.
